Drug Information
| Drug General Information | |||||
|---|---|---|---|---|---|
| Drug ID |
DX4SOX
|
||||
| Drug Name |
6-{2-[2-Hydroxy-3-(1H-indol-4-yloxy)-propylamino]-propoxy}-4H-benzo[1,4]oxazin-3-one
|
||||
| Synonyms |
CHEMBL183921
|
||||
| Indication | Discovery agent | Investigative | [1587926] | ||
| Formula |
C22H25N3O5
|
||||
| Canonical SMILES |
CC(COc1ccc2OCC(=O)Nc2c1)NCC(O)COc3cccc4[nH]ccc34
|
||||
| InChI |
InChI=1S/C22H25N3O5/c1-14(11-28-16-5-6-21-19(9-16)25-22(27)13-30-21)24-10-15(26)12-29-20-4-2-3-18-17(20)7-8-23-18/h2-9,14-15,23-24,26H,10-13H2,1H3,(H,25,27)
|
||||
| InChIKey |
WRLALEDDWSKGGQ-UHFFFAOYSA-N
|
||||
| Target and Pathway | |||||
| Target(s) | 5-hydroxytryptamine 1A receptor | Target Info | [1587926] | ||
| Sodium-dependent serotonin transporter | Target Info | [1587926] | |||
| NetPath Pathway | TCR Signaling Pathway | ||||
| PANTHER Pathway | Heterotrimeric G-protein signaling pathway-Gi alpha and Gs alpha mediated pathway | ||||
| 5HT1 type receptor mediated signaling pathwayP04373:5HT1 type receptor mediated signaling pathway | |||||
| 5HT2 type receptor mediated signaling pathway | |||||
| 5HT3 type receptor mediated signaling pathway | |||||
| 5HT4 type receptor mediated signaling pathway | |||||
| References | |||||
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.